Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad5-EBOV Vaccine in Healthy Adults in Sierra Leone
NCT02575456Phase 2Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Oct 2015
- Primary completion
- Jun 2016
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ad5-EBOV in Ebola virus disease (EVD), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Oct 2015; status: completed.
02
Drugs
Ad5-EBOV
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02575456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575456.